Scientists have long thought that these drugs, such as Adderall and Ritalin, target parts of the brain that control attention. But that may not be the case. Instead, stimulant medications for ADHD ...

Parkinson's disease and attention deficit hyperactivity disorder (ADHD) may be genetically linked, with effects on brain volume, a large study has found. "There is strong evidence that ADHD and ...

Over 5% of children and adolescents are diagnosed with attention deficit/hyperactivity disorder (ADHD) globally. This condition is characterized by a short attention span, hyperactivity or impulsive ...

A new study suggests that children with ADHD may exhibit a distinctive, measurable pattern of brain activity that could reflect differences in neural efficiency. The researchers focus on aperiodic EEG ...

For years, stimulant medications for ADHD have been described as chemical accelerators, framed as drugs that rev up a sluggish brain. New imaging work turns that story on its head. Brain scans now ...

The randomized, double-blind, sham-controlled trial evaluated 56 adults with ADHD who received four weeks of Nexalin’s ...

A new study published in Molecular Psychiatry reveals that the biological underpinnings of autism and ADHD may transcend traditional diagnostic boundaries. While there is increasing appreciation that ...

Forbes contributors publish independent expert analyses and insights. Alison Escalante M.D. covers neurodiversity, pediatrics and parenting. Stimulant medications are considered the first-line ...

ADHD is the most common neurobiological disorder in children. The key word being neurobiological. When in the throes of raising a neurodivergent child, it’s easy to forget that their behavior is ...

Stimulants prescribed for ADHD target the parts of the brain related to wakefulness and reward, shown in yellow and orange, according to a new study. Benjamin Kay In the United States, an estimated ...